Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
J Leukoc Biol. 2013 Jun;93(6):933-42. doi: 10.1189/jlb.1012498. Epub 2013 Mar 29.
RSV is the major cause of severe bronchiolitis in infants, and severe bronchiolitis as a result of RSV is associated with subsequent asthma development. A biased Th2 immune response is thought to be responsible for neonatal RSV pathogenesis; however, molecular mechanisms remain elusive. Our data demonstrate, for the first time, that IL-4Rα is up-regulated in vitro on human CD4(+) T cells from cord blood following RSV stimulation and in vivo on mouse pulmonary CD4(+) T cells upon reinfection of mice, initially infected as neonates. Th cell-specific deletion of Il4ra attenuated Th2 responses and abolished the immunopathophysiology upon reinfection, including airway hyper-reactivity, eosinophilia, and mucus hyperproduction in mice infected initially as neonates. These findings support a pathogenic role for IL-4Rα on Th cells following RSV reinfection of mice initially infected as neonates; more importantly, our data from human cells suggest that the same mechanism occurs in humans.
RSV 是婴儿严重细支气管炎的主要病因,由 RSV 引起的严重细支气管炎与随后的哮喘发展有关。人们认为,偏向性 Th2 免疫应答是导致新生儿 RSV 发病机制的原因;然而,其分子机制尚不清楚。我们的数据首次表明,RSV 刺激后体外培养的脐血人 CD4(+)T 细胞和再次感染的小鼠肺部 CD4(+)T 细胞中,IL-4Rα 上调,而这些小鼠最初在新生儿期被感染。Th 细胞特异性缺失 Il4ra 可减弱 Th2 反应,并消除再次感染时的免疫病理生理学,包括气道高反应性、嗜酸性粒细胞增多和最初感染的新生儿感染时的粘液过度产生。这些发现支持了 IL-4Rα 在 RSV 再次感染最初感染的新生儿小鼠 Th 细胞中的致病作用;更重要的是,我们从人类细胞获得的数据表明,同样的机制也存在于人类中。